TD Cowen Has Lowered Expectations for Colgate-Palmolive (NYSE:CL) Stock Price

Colgate-Palmolive (NYSE:CL) had its target price cut by TD Cowen from $115.00 to $110.00 in a research report released on Monday, Benzinga reports. They currently have a buy rating on the stock.

Several other analysts also recently weighed in on CL. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their target price for the company from $105.00 to $101.00 in a report on Monday. Evercore ISI lifted their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Morgan Stanley increased their target price on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Barclays lifted their target price on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Finally, Jefferies Financial Group cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price target for the stock from $103.00 to $95.00 in a research report on Wednesday, July 24th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $105.11.

Colgate-Palmolive Trading Down 0.0 %

Shares of CL stock opened at $94.69 on Monday. The company has a 50-day moving average of $102.69 and a two-hundred day moving average of $98.17. The firm has a market cap of $77.69 billion, a PE ratio of 29.97, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $73.97 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Insider Transactions at Colgate-Palmolive

In other news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Sally Massey sold 15,850 shares of the stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the sale, the executive vice president now owns 10,377 shares in the company, valued at $1,069,868.70. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 43,490 shares of company stock valued at $4,486,063. 0.34% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Colgate-Palmolive

Several hedge funds have recently modified their holdings of the stock. Radnor Capital Management LLC acquired a new position in shares of Colgate-Palmolive during the third quarter worth about $2,900,000. Catalina Capital Group LLC boosted its holdings in Colgate-Palmolive by 20.8% in the 3rd quarter. Catalina Capital Group LLC now owns 2,593 shares of the company’s stock valued at $269,000 after purchasing an additional 446 shares in the last quarter. Long Run Wealth Advisors LLC acquired a new position in Colgate-Palmolive during the 3rd quarter worth approximately $207,000. Fiduciary Family Office LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $704,000. Finally, Crestwood Advisors Group LLC lifted its holdings in shares of Colgate-Palmolive by 1.2% in the 3rd quarter. Crestwood Advisors Group LLC now owns 34,176 shares of the company’s stock valued at $3,548,000 after buying an additional 407 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.